AstraZeneca Advances Scientific Leadership in Hematology at ASH 2023
November 30, 2023
November 30, 2023
WILMINGTON, Delaware, Nov. 30 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
AstraZeneca will present new clinical and real-world data in multiple hematological conditions at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, December 9 to 12, 2023 in San Diego, CA.
A total of 63 abstracts will feature 14 approved and potential new medicines across the Company's portfolio and pipeline including from Alexion, Ast . . .
AstraZeneca will present new clinical and real-world data in multiple hematological conditions at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, December 9 to 12, 2023 in San Diego, CA.
A total of 63 abstracts will feature 14 approved and potential new medicines across the Company's portfolio and pipeline including from Alexion, Ast . . .